Fin + Min & Derma stamp for 1 year. Don't really notice much difference?
    5/19/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1 year
    💧 Minoxidil (topical) 9 months
    💊 Minoxidil (oral) 3 months
    💧 Derma stamp (topical) 1mm 1x weekly 1 year
    the tone is 😐 neutral with minimal noticeable hair regrowth results.

    Other terms

    The user has been using finasteride, minoxidil, and a derma stamp for a year with minimal noticeable hair regrowth, but others suggest there is slight improvement and recommend continuing the treatment. Some users suggest switching to dutasteride or adjusting the derma stamp technique for better results.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Androgenetic Alopecia: Causes, Treatments, and Genetic Factors

      research Androgenetic Alopecia

      1 citations , July 2018 in “Elsevier eBooks”
      This review covers androgenetic alopecia's epidemiology, pathogenesis, current management options, and research trends, concluding that no definitive cure exists despite extensive interest and ongoing genetic research efforts.
      Medical Treatments for Male and Female Pattern Hair Loss

      research Medical treatments for male and female pattern hair loss

      212 citations , September 2008 in “Journal of The American Academy of Dermatology”
      This review discusses the various treatment options for male and female pattern hair loss and provides no new clinical results; the authors outline the most effective strategies based on existing evidence.
      Nonsurgical Therapy for Hair Loss

      research Nonsurgical Therapy for Hair Loss

      14 citations , August 2013 in “Facial Plastic Surgery Clinics of North America”
      This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.
      Overactive Bladder in Men: Finasteride for Androgenetic Alopecia

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.
      Phytochemicals as Emerging Therapeutic Agents for Alopecia Treatment

      research Phytochemicals as emerging therapeutic agents for alopecia treatment

      January 2020 in “Elsevier eBooks”
      This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.
      Male Pattern Baldness: Current Treatments, Future Prospects

      research Male pattern baldness: current treatments, future prospects

      40 citations , July 2008 in “Drug Discovery Today”
      This review addresses the limited efficacy of current treatments for male pattern baldness and explains that emerging genetic insights could lead to more effective future therapies.